EZH2 and urinary bladder cancer: Recently, Wu revealed BRD4 as a novel promising target for pharmacologic treatment against bladder cancer and reported that BRD4 regulates proliferation and apoptosis of bladder cancer cells by positively regulating EZH2 transcription through upregulation of c-MYC (Wu et al., 2016).